The Use of GLP1R Agonists for the Treatment of Type 2 Diabetes in Kidney Transplant Recipients

Glucagon-like peptide-1 receptor agonists (GLP1RA) have been shown to improve glucose control and diabetes-related comorbidities in patients without solid organ transplants. The effectiveness, safety, and tolerability of GLP1RA after kidney transplantation have not been adequately studied. METHODS....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transplant Direct
Hlavní autoři: Kukla, Aleksandra, Hill, Jennifer, Merzkani, Massini, Bentall, Andrew, Lorenz, Elizabeth C., Park, Walter D., D’Costa, Matthew, Kudva, Yogish C., Stegall, Mark D., Shah, Pankaj
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Health 2020
Témata:
Kidney Transplantation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004635/
https://ncbi.nlm.nih.gov/pubmed/32095510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000971
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky